676 related articles for article (PubMed ID: 24627583)
1. Irritable bowel syndrome: emerging paradigm in pathophysiology.
Lee YJ; Park KS
World J Gastroenterol; 2014 Mar; 20(10):2456-69. PubMed ID: 24627583
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in the pathophysiology of irritable bowel syndrome.
El-Salhy M
World J Gastroenterol; 2015 Jul; 21(25):7621-36. PubMed ID: 26167065
[TBL] [Abstract][Full Text] [Related]
3. The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome.
El-Salhy M; Hausken T; Gilja OH; Hatlebakk JG
Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):139-148. PubMed ID: 27927062
[TBL] [Abstract][Full Text] [Related]
4. Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome.
El-Salhy M
World J Gastroenterol; 2020 Apr; 26(13):1427-1438. PubMed ID: 32308344
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of enteric neural function in irritable bowel syndrome.
O'Malley D
World J Gastroenterol; 2015 Jun; 21(24):7362-6. PubMed ID: 26139983
[TBL] [Abstract][Full Text] [Related]
6. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions.
Hyland NP; Quigley EM; Brint E
World J Gastroenterol; 2014 Jul; 20(27):8859-66. PubMed ID: 25083059
[TBL] [Abstract][Full Text] [Related]
7. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
Lee KN; Lee OY
World J Gastroenterol; 2014 Jul; 20(27):8886-97. PubMed ID: 25083061
[TBL] [Abstract][Full Text] [Related]
8. Sex hormones in the modulation of irritable bowel syndrome.
Mulak A; Taché Y; Larauche M
World J Gastroenterol; 2014 Mar; 20(10):2433-48. PubMed ID: 24627581
[TBL] [Abstract][Full Text] [Related]
9. Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.
Buckley MM; O'Mahony SM; O'Malley D
World J Gastroenterol; 2014 Jul; 20(27):8846-58. PubMed ID: 25083058
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of the irritable bowel syndrome.
Vaiopoulou A; Karamanolis G; Psaltopoulou T; Karatzias G; Gazouli M
World J Gastroenterol; 2014 Jan; 20(2):376-83. PubMed ID: 24574707
[TBL] [Abstract][Full Text] [Related]
11. Irritable bowel syndrome and visceral hypersensitivity : risk factors and pathophysiological mechanisms.
Deiteren A; de Wit A; van der Linden L; De Man JG; Pelckmans PA; De Winter BY
Acta Gastroenterol Belg; 2016 Mar; 79(1):29-38. PubMed ID: 26852761
[TBL] [Abstract][Full Text] [Related]
12. Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments.
Chang FY
World J Gastroenterol; 2014 Mar; 20(10):2499-514. PubMed ID: 24627587
[TBL] [Abstract][Full Text] [Related]
13. New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments.
Crowell MD; Harris L; Jones MP; Chang L
Curr Gastroenterol Rep; 2005 Aug; 7(4):272-9. PubMed ID: 16042910
[TBL] [Abstract][Full Text] [Related]
14. Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment.
Chang JY; Talley NJ
Trends Pharmacol Sci; 2010 Jul; 31(7):326-34. PubMed ID: 20554042
[TBL] [Abstract][Full Text] [Related]
15. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.
Ringel Y; Maharshak N
Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(8):G529-41. PubMed ID: 23886861
[TBL] [Abstract][Full Text] [Related]
16. Intestinal microbiota and its role in irritable bowel syndrome (IBS).
Ohman L; Simrén M
Curr Gastroenterol Rep; 2013 May; 15(5):323. PubMed ID: 23580243
[TBL] [Abstract][Full Text] [Related]
17. Probiotics and irritable bowel syndrome.
Dai C; Zheng CQ; Jiang M; Ma XY; Jiang LJ
World J Gastroenterol; 2013 Sep; 19(36):5973-80. PubMed ID: 24106397
[TBL] [Abstract][Full Text] [Related]
18. A review of the irritable bowel syndrome investigation on epidemiology, pathogenesis and pathophysiology in China.
Liu J; Hou X
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():88-93. PubMed ID: 21443718
[TBL] [Abstract][Full Text] [Related]
19. The Intestinal Microbiota and Irritable Bowel Syndrome.
Ringel Y; Ringel-Kulka T
J Clin Gastroenterol; 2015; 49 Suppl 1():S56-9. PubMed ID: 26447966
[TBL] [Abstract][Full Text] [Related]
20. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
